BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 6212042)

  • 1. Moxalactam therapy. Its use in chronic suppurative otitis media and malignant external otitis.
    Haverkos HW; Caparosa R; Yu VL; Kamerer D
    Arch Otolaryngol; 1982 Jun; 108(6):329-33. PubMed ID: 6212042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant external otitis. Cure with adjunctive hyperbaric oxygen therapy.
    Mader JT; Love JT
    Arch Otolaryngol; 1982 Jan; 108(1):38-40. PubMed ID: 6459078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study on cefmetazole and cefazolin in the treatment of suppurative otitis media].
    Baba S; Ito H; Kinoshita H; Murai K; Wada K; Sambe B; Kawamura S; Sugita R; Fujimaki Y; Kataura A; Sambe S; Watanabe H; Ikeda T; Nameki H; Tanaka M; Osawa H; Ikeda Y; Kawakubo J; Okuda M; Kamio T; Yagi T; Sekine S; Watanabe Y; Nomura Y; Miyakawa K; Yamaguchi H; Totsuka M; Kamio T; Yuge K; Nakamura K; Kubota T; Nakagawa T; Nakagawa M; Komatsuzaki A; Osafune H; Kojima S; Sakamoto Y; Honmura Y; Nakano Y; Imai A; Miyao M; Honda H; Iwasaki E; Iguchi M; Ikeda M; Hondoh J; Noda M; Umeda K; Maruo T; Deguchi K
    Jpn J Antibiot; 1982 Jun; 35(6):1523-52. PubMed ID: 6752467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ofloxacin otic solution as treatment of chronic suppurative otitis media and diffuse bacterial otitis externa.
    Sumitsawan Y; Tharavichitkul P; Prawatmuang W; Ingsuwan B; Sriburi P
    J Med Assoc Thai; 1995 Sep; 78(9):455-9. PubMed ID: 7561571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftazidime in the treatment of chronic suppurative otitis media in children.
    Lautala P; Vare M; Vuorinen O; Kaar ML
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():365-7. PubMed ID: 6352646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An experimental production of suppurative otitis media in dog, and a trial to evaluate the therapeutic effect of cefmetazole on this otitis media].
    Imori T; Matsuda H; Tohjo M; Kamata Y
    Jpn J Antibiot; 1982 Sep; 35(9):2277-87. PubMed ID: 6958884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy evaluation of aztreonam for suppurative otitis media].
    Baba S; Kinoshita H; Mori Y; Suzuki K; Furuuchi C; Baba K; Tanigaito Y; Nagae D; Kawai T; Maruo T
    Jpn J Antibiot; 1986 Jan; 39(1):159-76. PubMed ID: 3517406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ofloxacin in the treatment of Pseudomonas aeruginosa infections of the ear].
    Oberascher G; Karas C
    HNO; 1988 Jun; 36(6):230-3. PubMed ID: 3165974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of fluoroquinolones in chronic otitis suppurativa.
    van de Heyning PH; Pattyn SR; Valcke HD; van Caekenberghe DL; Claes J
    Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S87-9. PubMed ID: 3325935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of Burow's solution as an ear drop on Intractable chronic suppurative diseases of the external ear canal and middle ear].
    Terayama Y; Takizawa M; Gotouda H; Sutou S; Kashiwamura M
    Nihon Jibiinkoka Gakkai Kaiho; 2003 Jan; 106(1):28-33. PubMed ID: 12647321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of antibiotic resistant organisms with the use of ototopical medications.
    Weber PC; Roland PS; Hannley M; Friedman R; Manolidis S; Matz G; Owens F; Rybak L; Stewart MG
    Otolaryngol Head Neck Surg; 2004 Mar; 130(3 Suppl):S89-94. PubMed ID: 15054367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with Moxalactam in the treatment of pseudomonal and nonpseudomonal infections.
    Murphy TF; Barza M
    Antimicrob Agents Chemother; 1982 Apr; 21(4):568-74. PubMed ID: 6211137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas mastoiditis.
    Meyerhoff WL; Gates GA; Montalbo PJ
    Laryngoscope; 1977 Apr; 87(4 Pt 1):483-92. PubMed ID: 402522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of azlocillin in the treatment of Pseudomonas aeruginosa otitis in children].
    Damay M; Ployet MJ; Borderon JC
    Presse Med; 1984 Mar; 13(13):812-4. PubMed ID: 6231601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftazidime for outpatient parenteral antibiotic therapy (OPAT) of chronic suppurative otitis media due to Pseudomonas aeruginosa.
    Esposito S; Noviello S; Ianniello F; D'Errico G
    J Chemother; 2000 Feb; 12(1):88-93. PubMed ID: 10768520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of resistance to beta-lactam and aminoglycoside antibiotics during moxalactam therapy of Pseudomonas aeruginosa infections.
    Preheim LC; Penn RG; Sanders CC; Goering RV; Giger DK
    Antimicrob Agents Chemother; 1982 Dec; 22(6):1037-41. PubMed ID: 6218778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discharge from the ear: otitis externa and acute otitis media.
    Ludman H
    Br Med J; 1980 Dec; 281(6255):1616-7. PubMed ID: 7448539
    [No Abstract]   [Full Text] [Related]  

  • 18. Moxalactam therapy for gram-negative bacillary meningitis.
    Rahal JJ
    Rev Infect Dis; 1982; 4 Suppl():S606-9. PubMed ID: 6218572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of aminoglycoside versus fluoroquinolone topical antibiotic drops.
    Manolidis S; Friedman R; Hannley M; Roland PS; Matz G; Rybak L; Stewart MG; Weber P; Owens F
    Otolaryngol Head Neck Surg; 2004 Mar; 130(3 Suppl):S83-8. PubMed ID: 15054366
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current therapeutical management, new antibiotics and treatment of Pseudomonas aeruginosa in bacterial ENT-infections].
    Elies W
    Laryngorhinootologie; 2002 Jan; 81(1):40-5. PubMed ID: 11845401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.